Company intelligence / Profile preview
Fera Pharmaceuticals
Locust Valley, New York, United Statesferapharma.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Fera Pharmaceuticals is a specialty pharmaceutical company focused on preserving and expanding treatment options for patients with unmet needs, particularly in ophthalmology and orphan/niche indications. Its lead product is phospholine iodide for glaucoma. The company has acquired assets such as an abandoned pediatric glaucoma drug from Pfizer to expand its portfolio. It emphasizes maintaining access to essential medicines that might otherwise disappear from the market.
- Therapeutic areas
- OphthalmologyRare Diseases
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Not specifically listed; open to licensing/product development partnerships.
Beyond the preview
Go deeper on Fera Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fera Pharmaceuticals.